POM-V Prescription Required Companion Animal

Pulmotil G100 Premix for Medicated Feeding stuff

Active ingredient: Tilmicosin

Form

Premix

Species

Pigs Rabbits

Manufacturer

Elanco Europe Ltd

VMD MA No.

00879/5095

What it's used for

Rabbits: Prevention and treatment of respiratory disease caused by Pasteurella multocidaBordetella bronchiseptica tilmicosin.

Full indications, dosage and side effects ↓

View official SPC (PDF)

The prescription itself has a price. See what practices near you charge for a consultation and the written prescription fee.

Paying less for Tilmicosin

1

Ask your vet for a written prescription

They must provide one on request. Under the CMA Order the fee is capped at £21 from 2027.
2

Fill it at a registered online retailer

The CMA found online pharmacies 50–60% cheaper than practice dispensing on common medicines — typically £200–£300 a year.

Your prescription rights → VMD register of retailers →

Prescription required

Your vet must provide a written prescription on request. You can then purchase from any licensed online retailer.

Clinical information

Pulmotil G100 Premix for Medicated Feeding stuff — SPC Details

Source: VMD Summary of Product Characteristics (SPC). Last updated 27 Mar 2026.

Rabbits: Prevention and treatment of respiratory disease caused by
Pasteurella multocidaBordetella bronchiseptica
tilmicosin.

The intake of medicated feed depends on the clinical condition of the
animals. In order to obtain the correct dosage, the concentration of tilmicosin
may need to be adjusted accordingly.
Based on the recommended dose and the number and weight of animals to
be treated, the exact daily concentration of the veterinary medicinal product
should be calculated according to the following formula:
Pigs
Administer in the feed at a dose of 8 to 16 mg/kg body weight/day of
tilmicosin (equivalent to 200 to 400 ppm in the feed) for a period of 15 to 21
days.
IndicationDose rateDuration of
treatment
Inclusion rate in
feed
Prevention and
treatment of
respiratory
disease
8-16 mg/kg
bodyweight /day
15-21 days2-4 kg of the
veterinary
medicinal
product/tonne
Rabbits
Administer in the feed at 12.5 mg/kg body weight/day of tilmicosin
(equivalent to 200 ppm in the feed) for 7 days.
IndicationDose rateDuration of
treatment
Inclusion rate in feedPrevention and treatment of
respiratory disease
12.5 mg/kg
bodyweight /day
7 days2 kg of the veterinary
medicinal product/tonne
mg veterinary medicinal product/
kg body weight day
average body weight (kg)
of animals to be treated
xaverage daily feed intake
(kg/animal)
kg veterinary medicinal product
per tonne of feed
=xveterinary medicinal product
strength (g/kg)
To ensure thorough dispersion of the veterinary medicinal product, it should
first be mixed with a suitable quantity of feed ingredients (20-50 kg) before
incorporation into the finished feed.
This veterinary medicinal product can be incorporated into pelleted feed,
preconditioned for the minimum time-period at a temperature not exceeding
75°C.

Horses or other Equidae, must not be allowed access to feeds containing
tilmicosin. Horses fed with tilmicosin medicated feeds may present signs of
toxicity with lethargy, anorexia, reduction of feed consumption, loose stools,
colic, distension of the abdomen and death.
Do not use in case of hypersensitivity to the active substance or to any of the
excipients.

Pigs and rabbits:
Very rare
(<1 animal / 10,000 animals treated,
including isolated reports):
Reduced food intake
1
Transient
Reporting adverse events is important. It allows continuous safety monitoring
of a veterinary medicinal product. Reports should be sent, preferably via a
veterinarian, to either the marketing authorisation holder or the national
competent authority via the national reporting system. See the label for
respective contact details.

Under practical conditions, the management of respiratory disease outbreaks
recognises that acutely ill animals are inappetant and require parenteral
therapy.

Special precautions for safe use in the target species:
Inappropriate use of the veterinary medicinal product may increase the
prevalence of bacteria resistant to tilmicosin and may decrease the
effectiveness of treatment with tilmicosin related substances.
Use of the veterinary medicinal product should be based on identification and
susceptibility testing of the target pathogen(s). If this is not possible, therapy
should be based on epidemiological information and knowledge susceptibility
of the target pathogens at farm level, or at local/regional level.
Use of the veterinary medicinal product should be in accordance with official,
national and regional antimicrobial policies.
An antibiotic with a lower risk of antimicrobial resistance selection (lower
AMEG category) should be used for first line treatment where susceptibility
testing suggests the likely efficacy of this approach.
Special precautions to be taken by the person administering the veterinary
medicinal product to animals
Tilmicosin may induce irritation. Macrolides, such as tilmicosin, may also
cause hypersensitivity (allergy) following injection, inhalation, ingestion or
contact with skin or eye. Hypersensitivity to tilmicosin may lead to cross
reactions to other macrolides and vice versa. Allergic reactions to these
substances may occasionally be serious and therefore direct contact should
be avoided.
Personal protective equipment consisting of overalls, safety glasses,
impervious gloves and either a disposable half mask respirator conforming to
European Standard EN149 or a non-disposable respirator to European
Standard EN140 with a filter to EN143 should be worn when handling the
veterinary medicinal product.
Do not eat, drink or smoke when handling this veterinary medicinal product.
Wash hands after use.
In case of accidental ingestion, wash out mouth immediately with water and
seek medical advice immediately and show the label to the physician.
In case of accidental spillage onto skin, wash thoroughly with soap and water
and seek medical advice immediately and show the label to the physician.
In case of accidental eye contact, flush the eyes with plenty of clean, running
water and seek medical advice immediately and show the label to the
physician.
People with known hypersensitivity to tilmicosin should avoid contact with the
veterinary medicinal product.
If you develop symptoms following exposure, such as skin rash, seek
medical advice and show the label to the physician. Swelling of the face, lips
and eyes or difficulty in breathing are more serious symptoms and require
urgent medical attention.
Special precautions for the protection of the environment:
The primary route of environmental exposure is from manure applied to
agricultural land as fertilizer. Tilmicosin degrades/declines slowly in the soil.
Therefore, to protect soil and ground water, pig manure not to be spread
onto the grass land and when spread onto arable land plough to a depth of
30 cm. Environmental assessments have demonstrated that the use of the
veterinary medicinal product as indicated is not expected to have any impact
on the environment.
Other precautions:
Not applicable.

interaction
None known.

Store in a dry place.
Do not store above 25°C.
Protect from direct sunlight.

Pigs:
Meat and offal: 21 days.
Rabbits:
Meat and offal : 4 days.

This information is sourced from the official Summary of Product Characteristics (SPC) published by the Veterinary Medicines Directorate (VMD). It is provided for informational purposes only and does not replace professional veterinary advice. Always consult your vet before administering any medication.